Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement

Due to a large technical improvement in the past decade, transcatheter aortic valve replacement (TAVR) has expanded to lower-surgical-risk patients with symptomatic and severe aortic stenosis. While mortality rates related to TAVR are decreasing, the prognosis of patients is still impacted by ischem...

Descripción completa

Detalles Bibliográficos
Autores principales: Granger, Camille, Guedeney, Paul, Collet, Jean-Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031701/
https://www.ncbi.nlm.nih.gov/pubmed/35456283
http://dx.doi.org/10.3390/jcm11082190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031701/
https://www.ncbi.nlm.nih.gov/pubmed/35456283
http://dx.doi.org/10.3390/jcm11082190

Ejemplares similares